Related references
Note: Only part of the references are listed.p90 Ribosomal S6 Kinase 2, a Novel GPCR Kinase, Is Required for Growth Factor-Mediated Attenuation of GPCR Signaling
Ryan T. Strachan et al.
BIOCHEMISTRY (2010)
Prediction and Evaluation of Protein Farnesyltransferase Inhibition by Commercial Drugs
Amanda J. DeGraw et al.
JOURNAL OF MEDICINAL CHEMISTRY (2010)
Genetic Deletion of p90 Ribosomal S6 Kinase 2 Alters Patterns of 5-Hydroxytryptamine2A Serotonin Receptor Functional Selectivity
Ryan T. Strachan et al.
MOLECULAR PHARMACOLOGY (2010)
Directed molecular evolution of DREADDs: a generic approach to creating next-generation RASSLs
Shuyun Dong et al.
NATURE PROTOCOLS (2010)
Molecular Mechanisms of Action and In Vivo Validation of an M4 Muscarinic Acetylcholine Receptor Allosteric Modulator with Potential Antipsychotic Properties
Katie Leach et al.
NEUROPSYCHOPHARMACOLOGY (2010)
Structure-Based Design, Synthesis, and Biochemical and Pharmacological Characterization of Novel Salvinorin A Analogues as Active State Probes of the κ-Opioid Receptor
Feng Yan et al.
BIOCHEMISTRY (2009)
G-protein-coupled receptor-focused drug discovery using a target class platform approach
Ralf Heilker et al.
DRUG DISCOVERY TODAY (2009)
hERG-related drug toxicity and models for predicting hERG liability and QT prolongation
Emanuel Raschi et al.
EXPERT OPINION ON DRUG METABOLISM & TOXICOLOGY (2009)
Structural Determinants of G-protein α Subunit Selectivity by Regulator of G-protein Signaling 2 (RGS2)
Adam J. Kimple et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2009)
The topology of drug-target interaction networks: implicit dependence on drug properties and target families
Jordi Mestres et al.
MOLECULAR BIOSYSTEMS (2009)
Parallel Functional Activity Profiling Reveals Valvulopathogens Are Potent 5-Hydroxytryptamine2B Receptor Agonists: Implications for Drug Safety Assessment
Xi-Ping Huang et al.
MOLECULAR PHARMACOLOGY (2009)
DRUG DISCOVERY Predicting promiscuity
Andrew L. Hopkins
NATURE (2009)
Predicting new molecular targets for known drugs
Michael J. Keiser et al.
NATURE (2009)
Lorcaserin (APD356), a Selective 5-HT2C Agonist, Reduces Body Weight in Obese Men and Women
Steven R. Smith et al.
OBESITY (2009)
Structure-based discovery of β2-adrenergic receptor ligands
Peter Kolb et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2009)
Subtype-selective allosteric modulators of muscarinic receptors for the treatment of CNS disorders
P. Jeffrey Conn et al.
TRENDS IN PHARMACOLOGICAL SCIENCES (2009)
Conciliating binding efficiency and polypharmacology
Jordi Mestres et al.
TRENDS IN PHARMACOLOGICAL SCIENCES (2009)
Novel genetically encoded biosensors using firefly luciferase
Frank Fan et al.
ACS CHEMICAL BIOLOGY (2008)
Cell-based assays in GPCR drug discovery
Sandra Siehler
Biotechnology Journal (2008)
Anatomical Profiling of G Protein-Coupled Receptor Expression
Jean B. Regard et al.
CELL (2008)
Functional selectivity in GPCR modulator screening
Terry Kenakin
COMBINATORIAL CHEMISTRY & HIGH THROUGHPUT SCREENING (2008)
High throughput screening for orphan and liganded GPCRs
Shou-Hua Xiao et al.
COMBINATORIAL CHEMISTRY & HIGH THROUGHPUT SCREENING (2008)
Quantifying the relationships among drug classes
Jerome Hert et al.
JOURNAL OF CHEMICAL INFORMATION AND MODELING (2008)
Novel Selective Allosteric Activator of the M1 Muscarinic Acetylcholine Receptor Regulates Amyloid Processing and Produces Antipsychotic-Like Activity in Rats
Carrie K. Jones et al.
JOURNAL OF NEUROSCIENCE (2008)
Lorcaserin, a novel selective human 5-Hydroxytryptamine2C agonist:: In vitro and in vivo pharmacological characterization
William J. Thomsen et al.
JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS (2008)
Functional assays as prismatic views of drug activity: Relevance to new drug discovery
Terry Kenakin
JOURNAL OF RECEPTORS AND SIGNAL TRANSDUCTION (2008)
Network pharmacology: the next paradigm in drug discovery
Andrew L. Hopkins
NATURE CHEMICAL BIOLOGY (2008)
Structural diversity of G protein-coupled receptors and significance for drug discovery
Malin C. Lagerstrom et al.
NATURE REVIEWS DRUG DISCOVERY (2008)
Insights into the regulation of 5-HT2A serotonin receptors by scaffolding proteins and kinases
John A. Allen et al.
NEUROPHARMACOLOGY (2008)
Opportunities and challenges of psychiatric drug discovery: Roles for scientists in academic, industry, and government settings
P. Jeffrey Conn et al.
NEUROPSYCHOPHARMACOLOGY (2008)
Antagonism of dopamine D2 receptor/β-arrestin 2 interaction is a common property of clinically effective antipsychotics
Bernard Masri et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2008)
Environmental Studies of Schizophrenia Through the Prism of Epigenetics
Gabriel Oh et al.
SCHIZOPHRENIA BULLETIN (2008)
The 2.6 Angstrom Crystal Structure of a Human A2A Adenosine Receptor Bound to an Antagonist
Veli-Pekka Jaakola et al.
SCIENCE (2008)
The genetic design of signaling cascades to record receptor activation
Gilad Barnea et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2008)
High-resolution crystal structure of an engineered human β2-adrenergic G protein-coupled receptor
Vadim Cherezov et al.
SCIENCE (2007)
The pipeline and future of drug development in schizophrenia
J. A. Gray et al.
MOLECULAR PSYCHIATRY (2007)
Evolving the lock to fit the key to create a family of G protein-coupled receptors potently activated by an inert ligand
Blaine N. Armbruster et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2007)
Relating protein pharmacology by ligand chemistry
Michael J. Keiser et al.
NATURE BIOTECHNOLOGY (2007)
Dopamine agonists and the risk of cardiac-valve regurgitation
Rene Schade et al.
NEW ENGLAND JOURNAL OF MEDICINE (2007)
Valvular heart disease and the use of dopamine agonists for Parkinson's disease
Renzo Zanettini et al.
NEW ENGLAND JOURNAL OF MEDICINE (2007)
Heterotrimeric G-proteins: a short history
G Milligan et al.
BRITISH JOURNAL OF PHARMACOLOGY (2006)
Salvinorin A - From natural product to human therapeutics
Timothy A. Vortherms et al.
MOLECULAR INTERVENTIONS (2006)
The antinociceptive effect of Salvinorin A in mice
Trentini F. John et al.
EUROPEAN JOURNAL OF PHARMACOLOGY (2006)
Can we rationally design promiscuous drugs?
AL Hopkins et al.
CURRENT OPINION IN STRUCTURAL BIOLOGY (2006)
β-arrestin-dependent, G protein-independent ERK1/2 activation by the β2 adrenergic receptor
SK Shenoy et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2006)
Antinociceptive profile of salvinorin A, a structurally unique kappa opioid receptor agonist
CR McCurdy et al.
PHARMACOLOGY BIOCHEMISTRY AND BEHAVIOR (2006)
GPCR screening via ERK 1/2: A novel platform for screening G protein-coupled receptors
RIW Osmond et al.
JOURNAL OF BIOMOLECULAR SCREENING (2005)
High-throughput screening of G protein-coupled receptor antagonists using a bioluminescence resonance energy transfer 1-based β-arrestin2 recruitment assay
FF Hamdan et al.
JOURNAL OF BIOMOLECULAR SCREENING (2005)
High content screening for G protein-coupled receptors using cell-based protein translocation assays
C Grånäs et al.
COMBINATORIAL CHEMISTRY & HIGH THROUGHPUT SCREENING (2005)
High-content screening assay for activators of the Wnt/Fzd pathway in primary human cells
KM Borchert et al.
ASSAY AND DRUG DEVELOPMENT TECHNOLOGIES (2005)
The highly efficacious actions of N-desmethylclozapine at muscarinic receptors are unique and not a common property of either typical or atypical antipsychotic drugs:: is M1 agonism a pre-requisite for mimicking clozapine's actions?
MA Davies et al.
PSYCHOPHARMACOLOGY (2005)
Mining the receptorome
BN Armbruster et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2005)
Magic shotguns versus magic bullets: selectively non-selective drugs for mood disorders and schizophrenia
BL Roth et al.
NATURE REVIEWS DRUG DISCOVERY (2004)
Salvinorin A, an active component of the hallucinogenic sage Salvia divinorum is a highly efficacious κ-opioid receptor agonist:: Structural and functional considerations
C Chavkin et al.
JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS (2004)
Predicting GPCR-G-protein coupling using hidden Markov models
KR Sreekumar et al.
BIOINFORMATICS (2004)
Molecular mechanisms of ligand binding, signaling, and regulation within the superfamily of G-protein-coupled receptors: molecular modeling and mutagenesis approaches to receptor structure and function
K Kristiansen
PHARMACOLOGY & THERAPEUTICS (2004)
Fluorescent indicators of cAMP and Epac activation reveal differential dynamics of cAMP signaling within discrete subcellular compartments
LM DiPilato et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2004)
G-protein-coupled receptors at a glance
WK Kroeze et al.
JOURNAL OF CELL SCIENCE (2003)
Aripiprazole, a novel atypical antipsychotic drug with a unique and robust pharmacology
DA Shapiro et al.
NEUROPSYCHOPHARMACOLOGY (2003)
Evolution of key cell signaling and adhesion protein families predates animal origins
N King et al.
SCIENCE (2003)
Genome scan meta-analysis of schizophrenia and bipolar disorder, part III:: Bipolar disorder
R Segurado et al.
AMERICAN JOURNAL OF HUMAN GENETICS (2003)
Biochemical and pharmacological control of the multiplicity of coupling at G-protein-coupled receptors
E Hermans
PHARMACOLOGY & THERAPEUTICS (2003)
3,4-methylenedioxymethamphetamine (MDMA, Ecstasy) induces fenfluramine-like proliferative actions on human cardiac valvular interstitial cells in vitro
V Setola et al.
MOLECULAR PHARMACOLOGY (2003)
The G-protein-coupled receptors in the human genome form five main families.: Phylogenetic analysis, paralogon groups, and fingerprints
R Fredriksson et al.
MOLECULAR PHARMACOLOGY (2003)
Finding the intracellular signaling pathways affected by mood disorder treatments
JT Coyle et al.
NEURON (2003)
The G protein-coupled receptor repertoires of human and mouse
DK Vassilatis et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2003)
Bioinformatics approaches for the classification of G-protein-coupled receptors
A Gaulton et al.
CURRENT OPINION IN PHARMACOLOGY (2003)
The orphan G protein-coupled receptor GPR40 is activated by medium and long chain fatty acids
CP Briscoe et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2003)
Salvinorin A: the 'magic mint' hallucinogen finds a molecular target in the kappa opioid receptor
DJ Sheffler et al.
TRENDS IN PHARMACOLOGICAL SCIENCES (2003)
HI-histamine receptor affinity predicts short-term weight gain for typical and atypical antipsychotic drugs
WK Kroeze et al.
NEUROPSYCHOPHARMACOLOGY (2003)
G protein selectivity is regulated by multiple intracellular regions of GPCRs
SKF Wong
NEUROSIGNALS (2003)
Clozapine treatment for suicidality in schizophrenia - International Suicide Prevention Trial (InterSePT)
HY Meltzer et al.
ARCHIVES OF GENERAL PSYCHIATRY (2003)
RAMPs: 5 years on, where to now?
M Morfis et al.
TRENDS IN PHARMACOLOGICAL SCIENCES (2003)
A single-site, double-blind, placebo-controlled, dose-ranging study of YKP10A - a putative, new antidepressant
JD Amsterdam et al.
PROGRESS IN NEURO-PSYCHOPHARMACOLOGY & BIOLOGICAL PSYCHIATRY (2002)
Function of the serotonin 5-hydroxytryptamine 2B receptor in pulmonary hypertension
JM Launay et al.
NATURE MEDICINE (2002)
Salvinorin A:: A potent naturally occurring nonnitrogenous κ opioid selective agonist
BL Roth et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2002)
Functional effects of systemically administered agonists and antagonists of μ, δ, and κ opioid receptor subtypes on body temperature in mice
AK Baker et al.
JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS (2002)
The druggable genome
AL Hopkins et al.
NATURE REVIEWS DRUG DISCOVERY (2002)
The use of constitutively active GPCRs in drug discovery and functional genomics
DT Chalmers et al.
NATURE REVIEWS DRUG DISCOVERY (2002)
G protein-coupled receptor allosterism and complexing
A Christopoulos et al.
PHARMACOLOGICAL REVIEWS (2002)
Considerations for using fluorescence polarization in the screening of G protein-coupled receptors
P Banks et al.
JOURNAL OF BIOMOLECULAR SCREENING (2002)
Evidence for a model of agonist-induced activation of 5-hydroxytryptamine 2A serotonin receptors that involves the disruption of a strong ionic interaction between helices 3 and 6
DA Shapiro et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2002)
Novel Directions in Antipsychotic Target Identification using Gene Arrays
Michael G. Palfreyman et al.
CNS & NEUROLOGICAL DISORDERS-DRUG TARGETS (2002)
Constitutively Activated G Protein-Coupled Receptors: A Novel Approachto CNS Drug Discovery
Frederique Menzaghi et al.
CNS & NEUROLOGICAL DISORDERS-DRUG TARGETS (2002)
Double-blind, placebo-controlled study of INN 00835 (netamiftide) in the treatment of outpatients with major depression
JP Feighner et al.
INTERNATIONAL CLINICAL PSYCHOPHARMACOLOGY (2001)
G-protein-coupled receptors and signaling networks: emerging paradigms
MJ Marinissen et al.
TRENDS IN PHARMACOLOGICAL SCIENCES (2001)
Overexpression of the α1B-adrenergic receptor causes apoptotic neurodegeneration:: Multiple system atrophy
MJ Zuscik et al.
NATURE MEDICINE (2000)
Crystal structure of rhodopsin: A G protein-coupled receptor
K Palczewski et al.
SCIENCE (2000)
Share Paper
